Stock analysis, AI verdict, fundamentals & technical signals
Rating: SELL
Price: $30.60 Analyst target: $28.50 Upside: -6.86%
MEDNAX, Inc., provides neonatal, maternal-fetal, pediatric cardiology, and other pediatric subspecialties in the United States and Puerto Rico. The company is headquartered in Sunrise, Florida.
See the full interactive analysis & chart →Informational only — not investment advice.